Showing results (241-250 of 250) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2015
Clostridium butyricum Strains and Dysbiosis Linked to Necrotizing Enterocolitis in Preterm NeonatesNadim Cassir, Samia Benamar, Jacques Bou Khalil, et al.
Travel Medicine and Infectious Disease|June 29, 2020
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysisJean-Christophe Lagier, Matthieu Million, Philippe Gautret, et al.
Frontiers in Microbiology|February 24, 2022
Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in PandemicsPhilippe Colson, Pierre-Edouard Fournier, Hervé Chaudet, et al.
Travel Medicine and Infectious Disease|April 15, 2020
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational studyPhilippe Gautret, Jean-Christophe Lagier, Philippe Parola, et al.
Travel Medicine and Infectious Disease|May 11, 2020
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceMatthieu Million, Jean-Christophe Lagier, Philippe Gautret, et al.
Reviews in Cardiovascular Medicine|September 26, 2021
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatientsMatthieu Million, Jean-Christophe Lagier, Hervé Tissot-Dupont, et al.
Nature Microbiology|November 8, 2016
Culture of previously uncultured members of the human gut microbiota by culturomicsJean-Christophe Lagier, Saber Khelaifia, Maryam Tidjani Alou, et al.
Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2022
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Paul Bastard, Adrian Gervais, et al.
Science Immunology|August 20, 2021
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsPaul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Pageof 25